» Articles » PMID: 29021968

The Unyvero P55 'sample-in, Answer-out' Pneumonia Assay: A Performance Evaluation

Overview
Date 2017 Oct 13
PMID 29021968
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: O'Neill's recent Review on Antimicrobial Resistance expressed the view that by 2020 high-income countries should make it mandatory to support antimicrobial prescribing with rapid diagnostic evidence whenever possible.

Methods: Routine microbiology diagnosis of 95 respiratory specimens from patients with severe infection were compared with those generated by the Unyvero P55 test, which detects 20 pathogens and 19 antimicrobial resistance markers. Supplementary molecular testing for antimicrobial resistance genes, comprehensive culture methodology and 16S rRNA sequencing were performed.

Results: Unyvero P55 produced 85 valid results, 67% of which were concordant with those from the routine laboratory. Unyvero P55 identified more potential pathogens per specimen than routine culture (1.34 vs. 0.47 per specimen). Independent verification using 16S rRNA sequencing and culture (n = 10) corroborated 58% of additional detections compared to routine microbiology. Overall the average sensitivity for organism detection by Unyvero P55 was 88.8% and specificity was 94.9%. While Unyvero P55 detected more antimicrobial resistance markers than routine culture, some instances of phenotypic resistance were missed.

Conclusions: The Unyvero P55 is a rapid pathogen detection test for lower respiratory specimens, which identifies a larger number of pathogens than routine microbiology. The clinical significance of these additional organisms is yet to be determined. Further studies are required to determine the effect of the test in practise on antimicrobial prescribing and patient outcomes.

Citing Articles

Diagnostic Approach to Pneumonia in Immunocompromised Hosts.

Ullah N, Fusco L, Ametrano L, Bartalucci C, Giacobbe D, Vena A J Clin Med. 2025; 14(2).

PMID: 39860395 PMC: 11765643. DOI: 10.3390/jcm14020389.


The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document.

Candel F, Salavert M, Canton R, Del Pozo J, Galan-Sanchez F, Navarro D Crit Care. 2024; 28(1):440.

PMID: 39736683 PMC: 11687037. DOI: 10.1186/s13054-024-05224-3.


Rapid Molecular Diagnostics of Pneumonia Caused by Gram-Negative Bacteria: A Clinician's Review.

Pintea-Simon I, Bancu L, Mare A, Ciurea C, Toma F, Man A Antibiotics (Basel). 2024; 13(9).

PMID: 39334980 PMC: 11429159. DOI: 10.3390/antibiotics13090805.


Exploring the Utility of Multiplex Infectious Disease Panel Testing for Diagnosis of Infection in Different Body Sites: A Joint Report of the Association for Molecular Pathology, American Society for Microbiology, Infectious Diseases Society of....

Lewinski M, Alby K, Babady N, Butler-Wu S, Bard J, Greninger A J Mol Diagn. 2023; 25(12):857-875.

PMID: 37757952 PMC: 11702286. DOI: 10.1016/j.jmoldx.2023.08.005.


Trends in Molecular Diagnosis of Nosocomial Pneumonia Classic PCR vs. Point-of-Care PCR: A Narrative Review.

Balan A, Bodolea C, Tranca S, Hagau N Healthcare (Basel). 2023; 11(9).

PMID: 37174887 PMC: 10177880. DOI: 10.3390/healthcare11091345.


References
1.
Gadsby N, Russell C, McHugh M, Mark H, Morris A, Laurenson I . Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia. Clin Infect Dis. 2016; 62(7):817-823. PMC: 4787606. DOI: 10.1093/cid/civ1214. View

2.
Samuel L, Tibbetts R, Agotesku A, Fey M, Hensley R, Meier F . Evaluation of a microarray-based assay for rapid identification of Gram-positive organisms and resistance markers in positive blood cultures. J Clin Microbiol. 2013; 51(4):1188-92. PMC: 3666768. DOI: 10.1128/JCM.02982-12. View

3.
Jamal W, Al Roomi E, AbdulAziz L, Rotimi V . Evaluation of Curetis Unyvero, a multiplex PCR-based testing system, for rapid detection of bacteria and antibiotic resistance and impact of the assay on management of severe nosocomial pneumonia. J Clin Microbiol. 2014; 52(7):2487-92. PMC: 4097734. DOI: 10.1128/JCM.00325-14. View

4.
Suzuki E, Hiramatsu K, Yokota T . Survey of methicillin-resistant clinical strains of coagulase-negative staphylococci for mecA gene distribution. Antimicrob Agents Chemother. 1992; 36(2):429-34. PMC: 188452. DOI: 10.1128/AAC.36.2.429. View

5.
Livermore D . Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother. 2001; 47(3):247-50. DOI: 10.1093/jac/47.3.247. View